Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

RenovoRx (RNXT) EPS (Weighted Average and Diluted) (2024 - 2025)

RenovoRx's EPS (Weighted Average and Diluted) history spans 2 years, with the latest figure at -$0.08 for Q3 2025.

  • For Q3 2025, EPS (Weighted Average and Diluted) rose 20.0% year-over-year to -$0.08; the TTM value through Sep 2025 reached -$0.34, changed N/A, while the annual FY2024 figure was -$0.48, 51.99% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q3 2025 was -$0.08 at RenovoRx, roughly flat from -$0.08 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at -$0.07 in Q1 2024 and bottomed at -$0.11 in Q4 2024.